Levocarnitine may improve the survival of patients with liver cirrhosis who undergo cell-free and concentrated ascites reinfusion therapy for refractory ascites Hiromichi Kawaji,Akio Moriya,Teruya Nagahara,Yoshiaki Iwasaki,Masaharu AndoKanzo(2021)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要